Akèy › Skleroz an milti pwogresif kwonik › Ohio
Etid klinik pou Skleroz an milti pwogresif kwonik nan Ohio
6 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC), Columbus
- The Boster Center for Multiple Sclerosis, Columbus
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 30, 2026 · NCT07299019A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07840326A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC) L3-100, Columbus
- The Boster Center for Multiple Sclerosis, Columbus
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 22, 2026 · NCT07067463Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Cincinnati (UC) Waddell Center for Multiple Sclerosis, Cincinnati
- Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland
Ap rekriteFaz 3
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT04047628Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2025 · NCT05964829Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.